Evidence map›Paper›PMID 32705196›Full record

ArticleMolecular medicine reports2020

Effects of Egr1 on pancreatic acinar intracellular trypsinogen activation and the associated ceRNA network.

Bo Gao, Xueming Zhang, Dongbo Xue, Weihui Zhang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bo Gao *Department of General Surgery, Peking University People's Hospital, Beijing 100044, P.R. China.
Xueming Zhang *Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 100086, P.R. China.
Dongbo XueDepartment of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 100086, P.R. China.
Weihui ZhangDepartment of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 100086, P.R. China.
Harbin Medical University · CNPeking University People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute pancreatitis (AP) is a common digestive disorder with high morbidity and mortality. The present study aimed to investigate the expression of early growth response protein 1 (Egr1), and the effect of competing endogenous (ce)RNA network on trypsinogen activation. Pancreatic acinar intracellular trypsinogen activation (PAITA) is an important event in the early stage of AP; however, the underlying mechanisms remain unclear. The present study used taurolithocholic acid 3‑sulfate (TLC‑S)‑treated AR42J cells (pancreatic cell line) to establish a PAITA model. A gene microarray and bioinformatics analysis was performed to identify the potential key targets in PAITA. The results demonstrated that Egr1, an important transcription factor, was significantly overexpressed in PAITA. In Egr1 small interfering (si)RNA‑transfected cells, Egr1 expression was decreased and trypsinogen activation was significantly decreased compared with negative control siRNA‑transfected cells, indicating that in TLC‑S‑induced PAITA, overexpression of Egr1 enhanced trypsinogen activation. A ceRNA network [mRNA‑microRNA (miRNA/miR)‑long non‑coding (lnc)RNA] generated using the PAITA model revealed that the effects of Egr1 on PAITA may be regulated by multiple ceRNA pairs, and the lncRNAs (including NONRATT022624 and NONRATT031002) and miRNAs [including Rattus norvegicus (rno)‑miR‑214‑3p and rno‑miR‑764‑5p] included in the ceRNA pairs may serve roles in PAITA by regulating the expression of Egr1. The results of the present study may provide novel targets for researching the underlying mechanisms of, and developing treatments for AP.

Indexed as

Gene Regulatory NetworksAnimalsCell LineComputational BiologyEarly Growth Response Protein 1Enzyme ActivationGene Expression ProfilingMicroRNAsModels, BiologicalOligonucleotide Array Sequence AnalysisPancreatitisRatsRNA, Long NoncodingRNA, Small InterferingTaurolithocholic AcidTrypsinogenEarly Growth Response Protein 1Egr1 protein, ratMicroRNAsRNA, Long NoncodingRNA, Small InterferingTaurolithocholic Acidtaurolithocholic acid 3-sulfateTrypsinogenacute pancreatitisar42Jcompeting endogenous rnaearly growth response protein 1rypsinogen activation

Identifiers

PMID32705196
PMCPMC7411386
OpenAlexW3041023729

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.